Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$169.83
+1.2%
$175.34
$130.96
$182.89
$300.71B0.585.59 million shs2.18 million shs
Broadcom Inc. stock logo
AVGO
Broadcom
$1,253.15
+2.3%
$1,304.30
$601.29
$1,438.17
$580.73B1.252.94 million shs1.09 million shs
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$161.67
+0.7%
$159.21
$141.45
$163.14
$380.41B0.446.91 million shs3.52 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+0.92%+3.88%-5.89%+0.26%+3.40%
Broadcom Inc. stock logo
AVGO
Broadcom
+1.64%-6.58%-9.53%-0.15%+93.47%
The Procter & Gamble Company stock logo
PG
Procter & Gamble
+1.53%+3.29%-0.68%+4.27%+2.88%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.9236 of 5 stars
2.45.04.23.92.92.52.5
Broadcom Inc. stock logo
AVGO
Broadcom
4.834 of 5 stars
2.54.03.33.12.52.53.1
The Procter & Gamble Company stock logo
PG
Procter & Gamble
4.5163 of 5 stars
2.35.04.21.63.12.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.77
Moderate Buy$177.434.47% Upside
Broadcom Inc. stock logo
AVGO
Broadcom
2.91
Moderate Buy$1,285.412.57% Upside
The Procter & Gamble Company stock logo
PG
Procter & Gamble
2.67
Moderate Buy$168.884.46% Upside

Current Analyst Ratings

Latest AVGO, PG, and ABBV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/23/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$168.00 ➝ $170.00
4/22/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$172.00 ➝ $171.00
4/22/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$175.00 ➝ $182.00
4/17/2024
Broadcom Inc. stock logo
AVGO
Broadcom
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$1,405.00 ➝ $1,500.00
4/16/2024
Broadcom Inc. stock logo
AVGO
Broadcom
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$1,620.00
4/12/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$165.00 ➝ $168.00
4/8/2024
Broadcom Inc. stock logo
AVGO
Broadcom
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$1,500.00
4/3/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$170.00 ➝ $172.00
3/27/2024
AbbVie Inc. stock logo
ABBV
AbbVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$185.00 ➝ $195.00
3/22/2024
AbbVie Inc. stock logo
ABBV
AbbVie
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$188.00 ➝ $190.00
3/21/2024
Broadcom Inc. stock logo
AVGO
Broadcom
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$1,720.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$54.32B5.54$16.14 per share10.52$5.78 per share29.38
Broadcom Inc. stock logo
AVGO
Broadcom
$35.82B16.21$45.85 per share27.33$51.24 per share24.46
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$82.01B4.64$7.53 per share21.46$19.62 per share8.24

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.86B$2.7362.2113.992.148.95%162.28%14.62%4/26/2024 (Confirmed)
Broadcom Inc. stock logo
AVGO
Broadcom
$14.08B$26.9846.4527.082.4629.93%47.71%16.75%6/6/2024 (Estimated)
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$14.65B$6.1226.4223.303.1918.00%33.77%13.39%7/26/2024 (Estimated)

Latest AVGO, PG, and ABBV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/26/2024N/A
AbbVie Inc. stock logo
ABBV
AbbVie
$2.20N/A-$2.20N/AN/AN/A  
4/19/2024Q3 23
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$1.42$1.52+$0.10$1.52$20.43 billion$20.20 billion      
3/7/2024Q1 24
Broadcom Inc. stock logo
AVGO
Broadcom
$8.95$10.99+$2.04$14.26$11.79 billion$11.96 billion      
2/2/202412/31/2023
AbbVie Inc. stock logo
ABBV
AbbVie
$2.76$2.79+$0.03$5.12$14.02 billion$14.30 billion    
1/23/202412/31/2023
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$1.70$1.84+$0.14$2.28$21.48 billion$21.44 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.203.65%+7.84%227.11%52 Years
Broadcom Inc. stock logo
AVGO
Broadcom
$21.001.68%+12.58%77.84%14 Years
The Procter & Gamble Company stock logo
PG
Procter & Gamble
$4.032.49%+6.21%65.85%68 Years

Latest AVGO, PG, and ABBV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2024
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.553.54%4/12/20244/15/20245/15/2024
4/9/2024
The Procter & Gamble Company stock logo
PG
Procter & Gamble
quarterly$1.00652.57%4/18/20244/19/20245/15/2024
3/6/2024
Broadcom Inc. stock logo
AVGO
Broadcom
quarterly$5.251.49%3/20/20243/21/20243/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
5.02
0.87
0.76
Broadcom Inc. stock logo
AVGO
Broadcom
1.05
1.34
1.24
The Procter & Gamble Company stock logo
PG
Procter & Gamble
0.48
0.69
0.48

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Broadcom Inc. stock logo
AVGO
Broadcom
76.43%
The Procter & Gamble Company stock logo
PG
Procter & Gamble
65.77%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.25%
Broadcom Inc. stock logo
AVGO
Broadcom
2.00%
The Procter & Gamble Company stock logo
PG
Procter & Gamble
0.17%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.77 billion1.77 billionOptionable
Broadcom Inc. stock logo
AVGO
Broadcom
20,000463.42 million454.15 millionOptionable
The Procter & Gamble Company stock logo
PG
Procter & Gamble
107,0002.35 billion2.35 billionOptionable

AVGO, PG, and ABBV Headlines

SourceHeadline
R. Alexandra Keith Sells 855 Shares of The Procter & Gamble Company (NYSE:PG) StockR. Alexandra Keith Sells 855 Shares of The Procter & Gamble Company (NYSE:PG) Stock
marketbeat.com - April 23 at 12:21 PM
Barclays Raises Procter & Gamble (NYSE:PG) Price Target to $170.00Barclays Raises Procter & Gamble (NYSE:PG) Price Target to $170.00
marketbeat.com - April 23 at 11:57 AM
Procter & Gamble (NYSE:PG) Trading Up 0.5% After Analyst UpgradeProcter & Gamble (NYSE:PG) Trading Up 0.5% After Analyst Upgrade
marketbeat.com - April 23 at 11:29 AM
7 Dividend Stocks to Hold Onto During the Current Market Turbulence7 Dividend Stocks to Hold Onto During the Current Market Turbulence
investorplace.com - April 23 at 9:41 AM
Procter & Gamble: Falling Commodity Price Starts To Kick-InProcter & Gamble: Falling Commodity Price Starts To Kick-In
seekingalpha.com - April 23 at 8:23 AM
3 Super-Safe Stocks That Could Reach 70 Consecutive Years of Dividend Raises By 20323 Super-Safe Stocks That Could Reach 70 Consecutive Years of Dividend Raises By 2032
fool.com - April 23 at 6:15 AM
Procter & Gamble (NYSE:PG) Price Target Raised to $182.00 at Jefferies Financial GroupProcter & Gamble (NYSE:PG) Price Target Raised to $182.00 at Jefferies Financial Group
americanbankingnews.com - April 23 at 5:28 AM
Procter & Gamble (NYSE:PG) Price Target Cut to $171.00 by Analysts at Deutsche Bank AktiengesellschaftProcter & Gamble (NYSE:PG) Price Target Cut to $171.00 by Analysts at Deutsche Bank Aktiengesellschaft
americanbankingnews.com - April 23 at 4:40 AM
Procter & Gamble (NYSE:PG) Trading Up 1.3% After Strong EarningsProcter & Gamble (NYSE:PG) Trading Up 1.3% After Strong Earnings
americanbankingnews.com - April 23 at 1:38 AM
The Procter & Gamble Company (NYSE:PG) Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MAThe Procter & Gamble Company (NYSE:PG) Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA
marketbeat.com - April 22 at 11:39 PM
Procter & Gamble: Strong Sales Performance and Market Positioning Fuel Buy Rating with $175 Target PriceProcter & Gamble: Strong Sales Performance and Market Positioning Fuel Buy Rating with $175 Target Price
markets.businessinsider.com - April 22 at 3:34 PM
P&G Is Adapting To A New Reality Where It Can No Longer Rely On Price HikesP&G Is Adapting To A New Reality Where It Can No Longer Rely On Price Hikes
benzinga.com - April 22 at 3:34 PM
These Analysts Revise Their Forecasts On Procter & Gamble After Q3 ResultsThese Analysts Revise Their Forecasts On Procter & Gamble After Q3 Results
msn.com - April 22 at 3:34 PM
The Top 3 Retail Stocks to Buy in April 2024The Top 3 Retail Stocks to Buy in April 2024
investorplace.com - April 22 at 3:31 PM
7 Rock-Solid Dividend Stocks to Shower You With Reliable Income7 Rock-Solid Dividend Stocks to Shower You With Reliable Income
investorplace.com - April 22 at 1:30 PM
Procter & Gamble (NYSE:PG) PT Lowered to $171.00Procter & Gamble (NYSE:PG) PT Lowered to $171.00
marketbeat.com - April 22 at 12:12 PM
Procter & Gamble (NYSE:PG) Trading 1.3% Higher  After Better-Than-Expected EarningsProcter & Gamble (NYSE:PG) Trading 1.3% Higher After Better-Than-Expected Earnings
marketbeat.com - April 22 at 11:39 AM
Buy Rating on Procter & Gamble: Growth Prospects, Margin Expansion, and Sector DynamicsBuy Rating on Procter & Gamble: Growth Prospects, Margin Expansion, and Sector Dynamics
markets.businessinsider.com - April 22 at 10:33 AM
Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG) and Anheuser-Busch Inbev Sa (BUD)Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG) and Anheuser-Busch Inbev Sa (BUD)
markets.businessinsider.com - April 22 at 10:33 AM
The Procter & Gamble Company (NYSE:PG) Q3 2024 Earnings Call TranscriptThe Procter & Gamble Company (NYSE:PG) Q3 2024 Earnings Call Transcript
finance.yahoo.com - April 22 at 10:33 AM
Tide and Walmart Team Up to Expand Adoption of Washing in Cold with Consumers: For the Love of Their Laundry, Their Wallets and the PlanetTide and Walmart Team Up to Expand Adoption of Washing in Cold with Consumers: For the Love of Their Laundry, Their Wallets and the Planet
businesswire.com - April 22 at 10:00 AM
Procter & Gamble (NYSE:PG) Price Target Increased to $182.00 by Analysts at Jefferies Financial GroupProcter & Gamble (NYSE:PG) Price Target Increased to $182.00 by Analysts at Jefferies Financial Group
marketbeat.com - April 22 at 8:28 AM
Procter & Gamble (NYSE:PG) Announces  Earnings Results, Beats Estimates By $0.10 EPSProcter & Gamble (NYSE:PG) Announces Earnings Results, Beats Estimates By $0.10 EPS
americanbankingnews.com - April 22 at 7:04 AM
Procter & Gamble (NYSE:PG) Updates FY 2024 Earnings GuidanceProcter & Gamble (NYSE:PG) Updates FY 2024 Earnings Guidance
americanbankingnews.com - April 22 at 7:04 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AbbVie logo

AbbVie

NYSE:ABBV
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Broadcom logo

Broadcom

NASDAQ:AVGO
Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was founded in 1961 and is headquartered in Palo Alto, California.
Procter & Gamble logo

Procter & Gamble

NYSE:PG
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.